Introduction: The aim of this study is to clarify bilirubin parameters and its treatment in
preterm infants with bilirubin encephalopathy (pBE). Methods: We asked the responders to …

Objectives To examine the clinical characteristics of bilirubin encephalopathy in preterm
infants (pBE) in Japan. Methods We performed a two-step nationwide questionnaire survey …

Abstract In 1992, Kobe University proposed treatment criteria for hyperbilirubinemia in
newborns using total serum bilirubin and serum unbound bilirubin reference values. In the …

Aim: Describe the relation between levels of total serum bilirubin (TsB)≥ 450 μmol/L and
acute intermediate, acute advanced and chronic bilirubin encephalopathy. Material and …

Objective Bilirubin encephalopathy continued to be reported worldwide. This multicenter
study was conducted to explore the clinical characteristics, comorbidities and prognosis of …

Objective To compare the association of unbound bilirubin (UB), total serum bilirubin (TSB),
and bilirubin: albumin molar ratio (BAMR) with acute bilirubin encephalopathy (ABE), as …

CONTEXT: Severe neonatal hyperbilirubinemia is associated with chronic bilirubin
encephalopathy (kernicterus). OBJECTIVE: To systematically review the effectiveness of …

Most preterm infants less than 35 weeks gestational age (GA) have elevated total
serum/plasma bilirubin (TB) levels, which often present as jaundice, the yellowish …

Objective: To describe and compare infants with severe hyperbilirubinemia, who presented
with and without abnormal neurological findings and to identify associated risk factors. Study …

We performed the present study to summarize the recent epidemiological characteristics of
bilirubin encephalopathy and assess the role of total bilirubin-albumin ratio in the bilirubin …